Currently, Repligen Corp [RGEN] is trading at $150.1, up 0.92%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RGEN shares have gain 20.96% over the last week, with a monthly amount glided 20.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $150. Previously, Evercore ISI upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $155. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $150 on June 24, 2025. Wolfe Research upgraded its rating to a Outperform but $160 remained the price target by the analyst firm on April 29, 2025. Evercore ISI started tracking with a In-line rating for this stock on March 18, 2025, and assigned it a price target of $155. In a note dated February 10, 2025, TD Cowen initiated an Buy rating and provided a target price of $200 on this stock.
This stock has fluctuated between a low of $102.96 and a high of $182.52 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $171.67 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $150.1 at the most recent close of the market. An investor can expect a potential return of 14.37% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp [NASDAQ:RGEN] were 673.96M which represents 14.81% growth. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 147.87 points at the first support level, and at 145.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 151.54, and for the 2nd resistance point, it is at 152.98.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp [NASDAQ:RGEN] is 8.59. Also, the Quick Ratio is 7.32, while the Cash Ratio stands at 5.76. Considering the valuation of this stock, the price to sales ratio is 12.53, the price to book ratio is 4.10.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Sep 10 ’25 when 29111.0 shares were sold. Director, Hunt Anthony completed a deal on Sep 10 ’25 to buy 29111.0 shares. Meanwhile, Director Madaus Martin D bought 1800.0 shares on Aug 08 ’25.
